Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750

. 2021 Jan 18;22(2):894. doi: 10.3390/ijms22020894

PMCID: PMC7829958 PMID: 33477738

The authors wish to make the following corrections to this paper [1]:

Figure 2B was mistakenly replaced by Figure 2D, the corrected Figure 2 is shown below:

graphic file with name ijms-22-00894-i001.jpg

We apologize for any inconvenience brought to the readers.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

1.Abughanam G., Elkashty O.A., Liu Y., Bakkar M.O., Tran S.D. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019;20:4750. doi: 10.3390/ijms20194750. [DOI] [PMC free article] [PubMed] [Google Scholar]